Weibing Zhou Selected Research

Prostatic Neoplasms (Prostate Cancer)

3/2017

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weibing Zhou Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 12/2012
6	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2012
2	Nasopharyngeal Carcinoma 01/2020 - 09/2009
2	Glioma (Gliomas) 01/2020 - 11/2011
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	AIDS-Related Complex (ARC) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 03/2017

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2012 - 10/2012
1	etomoxirIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	LipidsIBA 12/2021
1	steroidogenic acute regulatory proteinIBA 12/2021
1	CholesterolIBA 12/2021
1	Small Cytoplasmic RNAIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2017
1	AndrogensIBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Genetic Markers (Genetic Marker)IBA 01/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2012
1	Temozolomide (Temodar)FDA LinkGeneric 11/2011

Therapy/Procedure

7	Radiotherapy 01/2022 - 09/2009
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020 - 09/2009
1	Radioimmunotherapy 01/2022
1	Immunotherapy 01/2020
1	Therapeutics 01/2020
1	Mastectomy (Mammectomy) 06/2019
1	Drug Therapy (Chemotherapy) 11/2011
1	Conformal Radiotherapy 11/2011